Piramal Pharma (PPLPHARMA) Share Price Falls 2.01% as Valuation and Peer Context Come Into Focus

Piramal Pharma Share Price opened the day under pressure and was last traded at Rs 202.15, down 2.01% from the previous close of Rs 206.3. The move left Piramal Pharma with a market capitalisation of Rs 27,931.68 crore, placing the company in the Large Cap category. As of 01 October 2026 at 9:53:06 AM IST, Piramal Pharma Share Price is trading below the previous close after a session that has so far stayed close to the opening level. Univest figures confirm the price action, but they do not point to a specific company trigger. That makes Piramal Pharma Stock News a question of price action, fundamentals and healthcare valuation rather than a single verified trigger. For readers tracking Piramal Pharma Share Price Today, the move is small in percentage terms but important because the stock is now being judged against sector metrics, peer multiples and its own profitability profile.

Piramal Pharma (PPLPHARMA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 202.15
Previous Close	Rs 206.3
Today's Move	-Rs 4.15 (-2.01%)
Open	Rs 206
High	Rs 207.1
Low	Rs 201.5
Market Capitalisation	Rs 27,931.68 crore
Market Cap Category	Large Cap

Piramal Pharma Share Price Today shows a clear intraday decline from Rs 206.3 to Rs 202.15, a fall of Rs 4.15. The stock opened at Rs 206, touched a high of Rs 207.1 and a low of Rs 201.5, which keeps the day’s range relatively tight around the previous close. That price structure indicates that Piramal Pharma Share Price is trading near the lower end of the range while staying close to the opening level. The company’s market capitalisation of Rs 27,931.68 crore classifies it as a Large Cap name, which is useful context when comparing Piramal Pharma Share Price with healthcare peers. For market readers, the main point is straightforward: Piramal Pharma Share Price has declined today, but the move is measured rather than extreme, and the next layer of analysis sits in the fundamentals.

Piramal Pharma Share Price Today also matters because the move comes without any verified company event attached to it. In Piramal Pharma Stock News terms, that keeps the focus on how the market is reading the stock’s current pricing versus earnings power, book value and sector norms. The day’s low of Rs 201.5 also shows that Piramal Pharma Share Price briefly traded below Rs 202, which is a useful marker for investors following price action and share price news on Univest. The next section looks at whether the company’s financial profile supports or challenges that move.

Piramal Pharma (PPLPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 27,931.68 crore
P/B Ratio	3.43x
ROE	-4.04%
ROCE	1.24%
EPS	Rs -2.36
Book Value Per Share	Rs 60.13
Dividend Yield	0%

Piramal Pharma (PPLPHARMA) fundamental metrics show P/B 3.43x, ROE -4.04%, ROCE 1.24%. Taken on their own, these numbers offer context rather than a trading signal.

Piramal Pharma has a market capitalisation of Rs 27,931.68 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 3.43x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -4.04% and ROCE of 1.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -2.36, book value per share of Rs 60.13, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.02x, median ROE of 11.7%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Benchmark Median P/E	32.02x
Benchmark Average P/E	49.17x
Benchmark P/E Range	3.4x to 688.17x
Company P/B Ratio	3.43x
Benchmark Median P/B	2.94x
Benchmark Average P/B	4.37x
Company ROE	-4.04%
Benchmark Median ROE	11.7%
Benchmark Average ROE	10.68%
Company ROCE	1.24%
Benchmark Median ROCE	13.61%
Benchmark Average ROCE	13.4%
Company Market Capitalisation	Rs 27,931.68 crore
Benchmark Median Market Cap	Rs 770.9 crore
Benchmark Average Market Cap	Rs 14,358.25 crore

Piramal Pharma (PPLPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Piramal Pharma (PPLPHARMA) has a ROE of -4.04%, which is below the benchmark median of 11.7%, a difference of -134.53%. Piramal Pharma (PPLPHARMA) has a ROCE of 1.24%, which is below the benchmark median of 13.61%, a difference of -90.89%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,46,276.3	36.1	5.05	14.85	19.11
Divi's Laboratories	DIVISLAB	2,51,531.48	84.24	13.95	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,86,956.51	83.74	20.35	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,19,221.66	25.71	4.3	19.69	21.39
Cipla	CIPLA	1,11,728.51	32.36	3.1	11.83	16

Its ROE of -4.04% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 1.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Piramal Pharma (PPLPHARMA) has a market capitalisation of Rs 27,931.68 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Piramal Pharma

• Piramal Pharma Share Price fell 2.01% to Rs 202.15, keeping today’s decline visible in the market.
• The stock trades in the Large Cap category with a market capitalisation of Rs 27,931.68 crore.
• Piramal Pharma Fundamental Analysis shows EPS of Rs -2.36, ROE of -4.04% and ROCE of 1.24%.
• The P/B ratio of 3.43 can be compared with the healthcare industry median of 2.94 and average of 4.37.
• Peer comparison shows stronger return profiles among several listed pharma names in the same industry.

About Piramal Pharma

Piramal Pharma operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of a large listed peer set that includes drug makers, specialty pharma names and healthcare businesses with different operating models. For investors reviewing Piramal Pharma Share Price and Piramal Pharma Company News, the key business context is that the stock belongs to a regulated, research-heavy industry where returns, pricing power and product mix can differ sharply across peers.

The latest Piramal Pharma Share Price Update should therefore be read alongside company financial ratios rather than in isolation. Piramal Pharma Share Price News on Univest is most useful when matched with valuation, book value and profitability data, because those figures shape how the market values a healthcare company of this size. In simple terms, Piramal Pharma is a pharmaceuticals business first, and today’s share price movement reflects how investors are weighing that business profile.

Track Piramal Pharma Share Price on Univest

Use Piramal Pharma (PPLPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Readers can track Piramal Pharma Share Price on Univest for live updates, valuation ratios, market capitalisation, 52-week levels and broader market insights. Piramal Pharma Stock Analysis on Univest also brings together Piramal Pharma Share Price Today, sector context and peer comparison in one place. For anyone following Piramal Pharma Latest News, Univest makes it easier to review the stock’s price move, fundamentals and company context without switching between multiple sources.

Frequently Asked Questions

What is Piramal Pharma Share Price today?

Ans. Piramal Pharma Share Price was Rs 202.15 as of 01 October 2026 at 9:53:06 AM IST. It was down 2.01% from the previous close of Rs 206.3, so today’s move is clearly negative.

Why is Piramal Pharma Share Price falling today?

Ans. Univest figures confirm the price action, but they do not point to a specific company trigger. Piramal Pharma Share Price is therefore being read through price action, valuation ratios and sector comparison rather than a verified trigger.

What does Piramal Pharma Share Price Today show?

Ans. Piramal Pharma Share Price Today shows a fall of Rs 4.15, with the stock opening at Rs 206, touching Rs 207.1 and Rs 201.5. The move stayed close to the opening level during the morning trade.

Is Piramal Pharma a Large Cap stock?

Ans. Yes. Piramal Pharma has a market capitalisation of Rs 27,931.68 crore, which places it in the Large Cap category. That size context matters when comparing Piramal Pharma Share Price with listed healthcare peers.

How is Piramal Pharma valued on book value and P/B?

Ans. Piramal Pharma has a book value of Rs 60.13 per share and a P/B ratio of 3.43. That is above the healthcare industry median P/B of 2.94 but below the industry average of 4.37.

What do EPS, ROE and ROCE say about Piramal Pharma?

Ans. EPS is Rs -2.36, ROE is -4.04% and ROCE is 1.24%. Those numbers indicate weak profitability and capital efficiency in the latest reported period, which keeps Piramal Pharma Fundamental Analysis in focus.

How does Piramal Pharma compare with healthcare peers?

Ans. Piramal Pharma Share Price sits below several large listed peers on market cap and below many peers on ROE and ROCE. Sun Pharma, Zydus Lifesciences, Cipla and others show stronger return ratios in the peer set.

Should investors track Piramal Pharma Share Price on Univest?

Ans. Yes, if they want one place to track Piramal Pharma Share Price Today, valuation ratios, market capitalisation and peer context. Univest also brings together Piramal Pharma Stock News and broader healthcare sector comparison.